1. Home
  2. RVMD vs RYAAY Comparison

RVMD vs RYAAY Comparison

Compare RVMD & RYAAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$154.30

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Logo Ryanair Holdings plc

RYAAY

Ryanair Holdings plc

HOLD

Current Price

$60.83

Market Cap

30.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
RYAAY
Founded
2014
1985
Country
United States
Ireland
Employees
883
25952
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
30.1B
30.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RVMD
RYAAY
Price
$154.30
$60.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
2
Target Price
$140.84
$78.00
AVG Volume (30 Days)
2.0M
1.6M
Earning Date
05-06-2026
05-18-2026
Dividend Yield
N/A
1.54%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.99
Revenue Next Year
$533.02
$6.32
P/E Ratio
N/A
$12.60
Revenue Growth
N/A
N/A
52 Week Low
$34.00
$53.14
52 Week High
$156.25
$74.24

Technical Indicators

Market Signals
Indicator
RVMD
RYAAY
Relative Strength Index (RSI) 62.04 58.70
Support Level $93.39 $60.51
Resistance Level N/A $61.47
Average True Range (ATR) 5.02 1.50
MACD -0.50 0.80
Stochastic Oscillator 81.16 85.54

Price Performance

Historical Comparison
RVMD
RYAAY

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About RYAAY Ryanair Holdings plc

Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.

Share on Social Networks: